samedan logo

 
 
spacer
home > ict > spring 2019 > e pluribus unum: out of many, one
PUBLICATIONS
International Clinical Trials

E Pluribus Unum: Out of Many, One

Drug development is a brutally competitive industry, with the total capitalised cost of bringing a successful new drug to market now exceeding US $2.5 billion, and, despite significant increases in R&D expenditure, returns are diminishing with experimental drugs gaining regulatory approval falling to one in 10. Adding to this dilemma are the costs associated with conducting clinical trials, which have risen at a rate 7.4% higher than inflation.

Life sciences organisations are in a race against time to reduce the ‘innovation gap’ in drug development and costs and are exploring numerous ways to curtail development timelines and increase the odds of successfully bringing new treatments to market, cumulating in significant investment in eClinical tools. According to research conducted by the Tufts Center for the Study of Drug Development, investments are bearing fruit, with 80% of organisations who have invested in eClinical technology reporting time savings and 30% shorter cycle times in comparison to those with inadequate technologies.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Craig Morgan is responsible for directing the global marketing strategy and team for the Oracle Health Sciences suite of study startup applications, working with sponsors, CROs, medical device manufacturers, and sites to reduce cycle times and improve collaboration and oversight in clinical trials. Craig is a technology and life sciences management professional with over 15 years’ experience in the application of informatics and bioinformatics to drug discovery and eClinical technology associated with starting clinical trials. He holds degrees in analytical chemistry, information systems, and business administration and is a certified project manager with the Project Management Institute.
spacer
Craig Morgan
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Signant Health Appoints Paul Drake as Chief Compliance and Security Officer

PHILADELPHIA, PA – December 17, 2019: Signant Health, announced today that it has appointed Paul Drake, PhD, MSc, as Chief Compliance and Security Officer. This role combines quality management, information security, physical security and regulatory compliance and is part of Signant Health’s ongoing commitment to invest in quality and data protection while accelerating innovation.
More info >>

White Papers

Utilising Big Data to Produce Faster and Cheaper Clinical Research

Medical Research Network (MRN) Limited

Recruitment and retention of patients remains the major challenge to ensuring trials run as fast as possible and give them the statistical power they are designed to produce. This is not just about getting better any more - but about stopping the deterioration of these metrics in modern clinical trials.
More info >>

 
Industry Events

SCOPE Summit for Clinical Ops Executives

18-21 February 2020, Hyatt Regency, Orlando, Florida, US

Celebrating its 11th successful year, SCOPE Summit 2020 takes place February 18-21 in Orlando, FL. Over the course of four stimulating days of in-depth discussions in 20 different conferences, 3 plenary keynote sessions, the annual Participant Engagement Awards, and the ever-popular interactive breakout discussions, the programming focuses on advances and innovative solutions in all aspects of clinical trial planning, management and operations
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement